Menu
  • Home
  • About
  • Distributors
  • Investors
Pressure BioSciences Inc
Menu
  • Technology
  • Products
  • Publications
  • Contract Services
  • Contact

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Audio and Video
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All Filings
    • Annual Reports
    • Proxy Statements
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

News / Events

  • Press Releases
  • IR Calendar
  • Audio and Video
  • Email Alerts

Pressure BioSciences Updates Stakeholders with Solid Progress on Key 2022 Goals: UST Commercial Release, Major Revenue Increase, Continued Financial Position Improvement, and Planned Uplist to National Market

Mar 17, 2022

Emerging Technology Insider Releases a New TechTalks Video Interview Featuring Richard T. Schumacher, CEO and Founder of Pressure BioSciences, Inc.

Mar 10, 2022

Ohio State Installs, Commissions New Pilot-Scale Ultra Shear Technology Processing Equipment for Preparation of Higher Quality and Safer Liquid Foods and Beverages

Mar 3, 2022

Pressure BioSciences Ultra Shear Technology Commercialization Achieves Key Milestone: Production-Scale System Commissioned at Ohio State to Serve Food Industry

Jan 27, 2022

Pressure BioSciences to Participate in FORCE Family Office's January 20th Webinar: Innovations and Advancements in the $4.6 Billion CBD Market

Jan 19, 2022

Pressure BioSciences Shatters Preconceived Nanoemulsion Stability, Performance, and Production Limits: Produces CBD Oil Nanoemulsions with 18 Month Stability

Dec 22, 2021

Pressure BioSciences, Inc. Q3 Financial Results Maintain Solid 2021 YTD Growth

Nov 17, 2021

Pressure BioSciences Awarded Second U.S. Patent for Its Revolutionary Ultra Shear Technology Platform, for Its Innovative NanoGap Valve

Nov 11, 2021

Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology

Nov 4, 2021

Pressure BioSciences to Participate in the Benzinga ALL ACCESS Investor Event

Nov 2, 2021
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...42

    Browse Our Site

    • Home
    • About
    • Distributors
    • Investors
    • Technology
    • Products
    • Publications
    • Contract Services
    • Contact

    Visit Us

    • Corporate Office
    • Pressure BioSciences, Inc.
    • 14 Norfolk Avenue
    • South Easton, MA 02375
    • Research & Development Laboratory
    • Pressure BioSciences, Inc.
    • Suite 1950
    • 200 Boston Avenue
    • Medford, MA 02155

    Connect With Us

    Talk To Us

    • P (508) 230.1828
    • F (508) 230.1829
    • E info@pressurebiosciences.com
    • SEND US A MESSAGE
    • Privacy Policy
    • Returns & Refunds
    • Terms & Conditions/Delivery & Shipment
    • Disclaimer

    © 2023 Pressure BioSciences, Inc. All Rights Reserved. Website by Interactive Palette